Literature DB >> 21763119

Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease.

María Inés Vargas-Rojas1, Alejandra Ramírez-Venegas, Leonardo Limón-Camacho, Leticia Ochoa, Rafael Hernández-Zenteno, Raúl H Sansores.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a progressive disorder characterized by an inflammatory response to cigarette smoke. A disorder in immune regulation contributing to the pathogenesis of COPD has been suggested, however, little is known about the involvement of CD4 (+) T cells. To determine the distribution of different CD4(+) T cell subsets in patients with COPD, current smokers without COPD (CS) and healthy subjects (HS), and its correlation with pulmonary function.
METHODS: Th1, Th2, Th17 and Treg, subsets, were quantified by flow cytometry in peripheral blood (PB) of 39 patients with COPD, 14 CS and 15 HS. Correlations were assessed with Spearman's rank test. The association between Th17 and lung function was evaluated with a multivariate logistic regression analysis.
RESULTS: An increase of Th17 cells (median 9.7% range 0.8-22.5%) was observed in patients with COPD compared with CS (median 2.8% range 0.8-10.6) and HS (median 0.6% range 0.4-1%, p < 0.0001). Th1 and Tregs subsets were also increased in COPD and CS compared to HS. Inverse correlations were found between Th17 with FEV(1)%p r = -0.57 and with FEV(1)/FVC r = -0.60, (p < 0.0001 for both comparison). In addition, increase of Th17 predicted the presence [OR 1.76 (CI 95% 1.25-2.49, p = 0.001)] and severity of airflow limitation [OR 1.13 (CI95% 1.02-1.25, p = 0.02)].
CONCLUSIONS: The increase of Th17 response and the lost of balance between CD4(+) T cell subsets, suggest a lack of regulation of the systemic inflammatory response that may contribute to pathogenesis in COPD patients.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763119     DOI: 10.1016/j.rmed.2011.05.017

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  59 in total

1.  IL-22 promotes the proliferation of cancer cells in smoking colorectal cancer patients.

Authors:  Bao Song; Yuan Ma; Xiuchun Liu; Wanhu Li; Jianbo Zhang; Jie Liu; Jinxiang Han
Journal:  Tumour Biol       Date:  2015-08-22

2.  CD4+ T-Cell Profiles and Peripheral Blood Ex-Vivo Responses to T-Cell Directed Stimulation Delineate COPD Phenotypes.

Authors:  Mustimbo E P Roberts; Brandon W Higgs; Philip Brohawn; Fernanda Pilataxi; Xiang Guo; Michael Kuziora; Russell P Bowler; Wendy I White
Journal:  Chronic Obstr Pulm Dis       Date:  2015-08-23

3.  Central role of T helper 17 cells in chronic hypoxia-induced pulmonary hypertension.

Authors:  Levi D Maston; David T Jones; Wieslawa Giermakowska; Tamara A Howard; Judy L Cannon; Wei Wang; Yongyi Wei; Weimin Xuan; Thomas C Resta; Laura V Gonzalez Bosc
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-02-17       Impact factor: 5.464

Review 4.  T-cell biology in aging, with a focus on lung disease.

Authors:  Naeun Lee; Min Sun Shin; Insoo Kang
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-05       Impact factor: 6.053

5.  Infiltration of IL-17-Producing T Cells and Treg Cells in a Mouse Model of Smoke-Induced Emphysema.

Authors:  Min-Chao Duan; Jian-Quan Zhang; Yue Liang; Guang-Nan Liu; Jin Xiao; Hai-Juan Tang; Yi Liang
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

6.  Functional status of immune cells in patients with long-lasting type 2 diabetes mellitus.

Authors:  H W Nam; Y J Cho; J A Lim; S J Kim; H Kim; S Y Sim; D G Lim
Journal:  Clin Exp Immunol       Date:  2018-09-12       Impact factor: 4.330

7.  Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease.

Authors:  Vandana Gupta; Antonia Banyard; Aoibheann Mullan; Srividya Sriskantharajah; Thomas Southworth; Dave Singh
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

Review 8.  Interluekin-17A (IL17A).

Authors:  Kong Chen; Jay K Kolls
Journal:  Gene       Date:  2017-01-22       Impact factor: 3.688

9.  The protective effects of bone mesenchymal stem cells on paraquat-induced acute lung injury via the muc5b and ERK/MAPK signaling pathways.

Authors:  Lichun Zhang; Qiuhe Li; Zhenning Liu; Yu Wang; Min Zhao
Journal:  Am J Transl Res       Date:  2019-06-15       Impact factor: 4.060

Review 10.  Dysregulation in lung immunity - the protective and pathologic Th17 response in infection.

Authors:  Emily E Way; Kong Chen; Jay K Kolls
Journal:  Eur J Immunol       Date:  2013-10-16       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.